Incorporating protein flexibility into docking and structure-based drug design

被引:25
|
作者
Barril, Xavier [1 ,2 ]
Fradera, Xavier [3 ]
机构
[1] ICREA, Barcelona 08028, Spain
[2] Univ Barcelona, Fac Farm, Dept Fis Quim, E-08028 Barcelona, Spain
[3] Organon Labs Ltd, Organon Res Scotland, Dept Med Chem, Newhouse ML1 5SH, Lancs, England
关键词
allostery; conformational flexibility; docking; induced-fit; structure-based drug design;
D O I
10.1517/17460441.1.4.335
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of structure in drug design has become widespread, mainly thanks to recent advances in crystallography. Nevertheless, biological macromolecules are intrinsically flexible and it is increasingly evident that their function depends critically on both their structure and dynamics. In this review the authors discuss the implications of protein flexibility for drug design and review recent progress in incorporating protein flexibility into docking and structure-based drug design.
引用
收藏
页码:335 / 349
页数:15
相关论文
共 50 条
  • [2] Protein flexibility:: The ultimate limitation to structure-based drug design?
    Rauh, D
    Günther, J
    Stubbs, MT
    Klebe, G
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U790 - U790
  • [3] Protein structure-based drug design: from docking to molecular dynamics
    Sledz, Pawel
    Caflisch, Amedeo
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2018, 48 : 93 - 102
  • [4] Structure-based drug design: Docking and scoring
    Kroemer, Romano T.
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (04) : 312 - 328
  • [5] Relationship between Protein Flexibility and Binding: Lessons for Structure-Based Drug Design
    Alvarez-Garcia, Daniel
    Barril, Xavier
    [J]. JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2014, 10 (06) : 2608 - 2614
  • [6] Molecular Docking and Structure-Based Drug Design Strategies
    Ferreira, Leonardo G.
    dos Santos, Ricardo N.
    Oliva, Glaucius
    Andricopulo, Adriano D.
    [J]. MOLECULES, 2015, 20 (07) : 13384 - 13421
  • [7] Ligand docking for structure-based drug design.
    Jiang, X
    Venkatachalam, CM
    Oldfield, T
    Waldman, M
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U697 - U697
  • [8] PROTEIN STRUCTURE-BASED DRUG DESIGN
    WHITTLE, PJ
    BLUNDELL, TL
    [J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1994, 23 : 349 - 375
  • [9] Protein flexibility is an important component of structure-based drug discovery
    Carlson, HA
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (17) : 1571 - 1578
  • [10] Computational structure-based drug design: Predicting target flexibility
    Iglesias, Jelisa
    Saen-oon, Suwipa
    Soliva, Robert
    Guallar, Victor
    [J]. WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2018, 8 (05)